JARC - EU Joint Action on Rare Cancers

The Joint Action on Rare Cancers (JARC) is aimed to integrate and maximize efforts of the European Union (EU) Commission, EU Member States and all stakeholders to advance quality of care and research on rare cancers.

The framework for EU stakeholders and policy makers to work together, set the agenda at national level and help provide diagnostics, healthcare and support to all our citizens who suffer from rare cancer.

Deliverable : Rare cancer agenda 2030, Ten Recommendations from the EU Joint Action on Rare Cancers

JARC website

JARC objectives